bioAffinity Technologies
BIAFW
4 hedge funds and large institutions have $55.9K invested in bioAffinity Technologies in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
29% more capital invested
Capital invested by funds: $43.3K → $55.9K (+$12.6K)
0.43% more ownership
Funds ownership: 7.81% → 8.24% (+0.43%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.16K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$140 |
| 3 |
CS
Clear Street
New York
|
-$36 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $24.9K | -$36 | -114 | -0.2% |
|
|
2
UBS Group
Zurich,
Switzerland
| $20.9K | -$140 | -440 | -0.9% |
|
|
3
Citadel Advisors
Miami,
Florida
| $6.55K | -$1.16K | -3,648 | -16% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3.63K | +$3.49K | +11,013 | New |
|
BIAFW Hedge Fund Activity: Q1 2026 in Review
4 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q1 2026, worth a combined $55.9K — up 29% from $43.3K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIAFW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.49K. The largest seller was Citadel Advisors, cutting an estimated $1.16K.
- 4 institutional investors held bioAffinity Technologies (BIAFW) as of Q1 2026, up from 3 in Q4 2025.
- Funds reported $55.9K of bioAffinity Technologies stock for Q1 2026, up 29% quarter-over-quarter.
- 1 fund opened new bioAffinity Technologies positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest bioAffinity Technologies buyer in Q1 2026 was Susquehanna International Group, an estimated $3.49K added.
- The largest bioAffinity Technologies seller in Q1 2026 was Citadel Advisors, an estimated $1.16K sold.
Based on aggregated 13F filings for Q1 2026.